Phase II study of NCX-470 in open-angle glaucoma or ocular hypertension meets primary endpoint Oct. 2, 2019 No Comments
Ectopic expression of human melanopsin in RGCs restores visual function in animal models Sep. 26, 2019 No Comments
GenSight reports week 96 data from phase III RESCUE trial of GS-010 in LHON Sep. 23, 2019 No Comments
Boehringer and Inflammasome partner to develop novel therapies for retinal diseases Sep. 23, 2019 No Comments
Boehringer Ingelheim taps Inflammasome Therapeutics in $160M retinal disease deal Sep. 23, 2019 By Michael Fitzhugh No Comments
Claudin-5 is a key mediator of retinal pigment epithelium pathology regulated by the circadian clock Sep. 18, 2019 No Comments
Adverum reports 24-week cohort 1 data from phase I study of ADVM-022 in wet AMD Sep. 12, 2019 No Comments
RSS